Treeline Biosciences, Inc., a biotechnology company based in Watertown, MA, has successfully completed a fundraising round, raising $200.1 million as reported in their SEC Form D filing dated September 4, 2025. The total offering amount was set at $250 million, indicating strong investor interest.
Related articles
Press ReleaseMay 25, 2026
FinVolution Group Announces New Share Repurchase Program of Up to US$150 million
May 25, 2026
Press ReleaseMay 25, 2026
TECO Signs Acquisition Agreement with Malaysia's Dynaciate, Targeting Exponential AIDC Revenue Growth Next Year
May 25, 2026
Press ReleaseMay 25, 2026
Cyient Semiconductors Announces Strategic Financing with Edelweiss at ~ USD 500 Mn. Equity Valuation
May 25, 2026
← Back to all articles
Generated by Olivia 6